Patents Assigned to Glutagen Pty Ltd.
  • Publication number: 20230173040
    Abstract: The present invention is generally related to methods of digesting ?-amylase/trypsin inhibitors (ATI), and to the treatment and/or prophylaxis of an ?-amylase/trypsin inhibitor (ATI) mediated conditions.
    Type: Application
    Filed: May 12, 2021
    Publication date: June 8, 2023
    Applicant: GLUTAGEN PTY LTD
    Inventors: Michelle Lisa COLGRAVE, Angéla JUHÁSZ, Gregory John TANNER, Ezequiel PENA
  • Patent number: 10457929
    Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: October 29, 2019
    Assignee: Glutagen Pty Ltd.
    Inventors: Teodor Stelmasiak, Hugh James Beatty Cornell
  • Patent number: 10100296
    Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analog or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: October 16, 2018
    Assignee: Glutagen Pty Ltd
    Inventors: Teodor Stelmasiak, Hugh James Beatty Cornell
  • Publication number: 20120034299
    Abstract: The present invention provides compositions for use in the prophylaxis or treatment of a condition arising from gluten intolerance, the compositions including at least partially purified caricain (or a biologically active fragment, analogue or variant thereof) alone or in combination with other suitable enzymes including bromelain, and/or an intestinal extract, as herein described. The present invention also provides methods of using such compositions for the prophylaxis or treatment of a condition arising from gluten intolerance.
    Type: Application
    Filed: January 6, 2010
    Publication date: February 9, 2012
    Applicant: Glutagen Pty Ltd.
    Inventors: Teodor Stelmasiak, Hugh James Beatty Cornell